Taro Pharmaceuticals U.S.A. Issues Voluntary Nationwide Recall of Clobetasol Propionate Ointment USP, 0.05%, 60 g Tubes, Lot AC13786 Due to Microbial Contamination

Date: 12/30/2021

Product type: Drugs, Potential Foreign Material

Company Announcement Date: December 27, 2021
FDA Publish Date: December 30, 2021
Product Type: Drugs
Reason for Announcement: Presence of Ralstonia pickettii bacteria
Company Name: Taro Pharmaceuticals USA, Inc.
Brand Name: Taro
Product Description: Clobetasol Propionate

USA-FDA Link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/taro-pharmaceuticals-usa-issues-voluntary-nationwide-recall-clobetasol-propionate-ointment-usp-005